PE Tech Report


Like this article?

Sign up to our free newsletter

Hermes GPE bolsters investment capabilities with two new hires

Hermes GPE, a specialist investor in global private equity, has appointed two new senior investment professionals, Sanjeev Phakey and Fidel Manolopoulos (pictured), who will both be based in the firm’s London office. 

These appointments bring Hermes GPE’s investment team to 20 professionals across three offices in London, New York and Singapore.
Phakey joins Hermes GPE from the Universities Superannuation Scheme (USS) where he spent six years working across the private markets platform. Phakey joins Hermes GPE to focus on fund and co-investments in the EMEA region, which is led by Simon Moss. Prior to joining USS, he worked at a boutique advisory firm, having trained as an analyst in the consumer and retail investment banking team at UBS. Hermes GPE recently announced that it had raised circa USD620 million for its global co-investment platform over the last eighteen months, closing its third pooled co-investment fund, PEC III, in September 2017. PEC III has now committed to 33 investments. 
Fidel’s appointment is being made to bolster Hermes GPE’s direct growth equity capabilities and to help foster closer partnerships with GPs and investors focusing on sustainable growth businesses across Europe and North America. Manolopoulos has a strong background in technology growth investing gained over several years at ViewPoint Capital and Kennet Partners and joins from Mojo Capital where he was recently leading direct investments. Alongside its co-investment and fund investing platform, Hermes GPE manages niche investment programs which focus on companies across fast growing segments and themes in consumer, healthcare, education, fintech and sustainability, including the Hermes GPE Environmental Innovation Fund.
Peter Gale, Head of Hermes GPE Private Equity, says: ‘Both Sanjeev and Fidel bring a wealth of investment experience and strong GP networks that will reinforce our deal-flow, as well as deepen our relationships with GPs and investors in the growth and mid-market space. These two appointments are timely and mean that our business is well-positioned for what promises to be a busy 2018.”

Like this article? Sign up to our free newsletter